SARS-Cov-2 Induced Pulmonary Fibrosis
1 clinical trials · Condition
◉ Watch SARS-Cov-2 Induced Pulmonary Fibrosis
| Record | Firm | Date |
|---|---|---|
| Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis (NCT04541680) | Assistance Publique - Hôpitaux de Paris | 2020-10-29 |
Track SARS-Cov-2 Induced Pulmonary Fibrosis automatically
Every clearance here is in the API, with alerts when new ones post.